Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Theranostics 2023; 13(4):1287-1288. doi:10.7150/thno.82636 This issue Cite

Erratum

Transcriptional Downregulation of miR-4306 serves as a New Therapeutic Target for Triple Negative Breast Cancer: Erratum

Zitong Zhao1, Lin Li4, Peina Du4, Liying Ma1, Weimin Zhang6, Leilei Zheng1, Bo Lan3, Bailin Zhang5, Fei Ma3, Bo Xu2, Qimin Zhan1,6✉, Yongmei Song1✉

1. State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
2. Breast Cancer Center and the Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China
3. Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
4. BGI-Shenzhen, Shenzhen, Guangdong 518083, China
5. Department of Breast Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
6. Laboratory of Molecular Oncology, Peking University Cancer Hospital, Beijing 100142, China

✉ Corresponding authors: Yongmei Song, email: symlh2006com or songymac.cn and Qimin Zhan, email: qiminzhan163.com or zhanqiminedu.cn

Citation:
Zhao Z, Li L, Du P, Ma L, Zhang W, Zheng L, Lan B, Zhang B, Ma F, Xu B, Zhan Q, Song Y. Transcriptional Downregulation of miR-4306 serves as a New Therapeutic Target for Triple Negative Breast Cancer: Erratum. Theranostics 2023; 13(4):1287-1288. doi:10.7150/thno.82636. https://www.thno.org/v13p1287.htm
Other styles

File import instruction

Corrected-article in Theranostics, Volume 9, 1401

Citation styles

APA
Zhao, Z., Li, L., Du, P., Ma, L., Zhang, W., Zheng, L., Lan, B., Zhang, B., Ma, F., Xu, B., Zhan, Q., Song, Y. (2023). Transcriptional Downregulation of miR-4306 serves as a New Therapeutic Target for Triple Negative Breast Cancer: Erratum. Theranostics, 13(4), 1287-1288. https://doi.org/10.7150/thno.82636.

ACS
Zhao, Z.; Li, L.; Du, P.; Ma, L.; Zhang, W.; Zheng, L.; Lan, B.; Zhang, B.; Ma, F.; Xu, B.; Zhan, Q.; Song, Y. Transcriptional Downregulation of miR-4306 serves as a New Therapeutic Target for Triple Negative Breast Cancer: Erratum. Theranostics 2023, 13 (4), 1287-1288. DOI: 10.7150/thno.82636.

NLM
Zhao Z, Li L, Du P, Ma L, Zhang W, Zheng L, Lan B, Zhang B, Ma F, Xu B, Zhan Q, Song Y. Transcriptional Downregulation of miR-4306 serves as a New Therapeutic Target for Triple Negative Breast Cancer: Erratum. Theranostics 2023; 13(4):1287-1288. doi:10.7150/thno.82636. https://www.thno.org/v13p1287.htm

CSE
Zhao Z, Li L, Du P, Ma L, Zhang W, Zheng L, Lan B, Zhang B, Ma F, Xu B, Zhan Q, Song Y. 2023. Transcriptional Downregulation of miR-4306 serves as a New Therapeutic Target for Triple Negative Breast Cancer: Erratum. Theranostics. 13(4):1287-1288.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use